Literature DB >> 12905064

Acute pancreatitis, expression of inducible nitric oxide synthase and defective insulin secretion.

Saleem S Qader1, Mats Ekelund, Roland Andersson, Stefanie Obermuller, Albert Salehi.   

Abstract

A high level of nitric oxide (NO) produced by inducible NO synthase (iNOS) is involved in pancreatic beta-cell dysfunction and apoptosis. In the present study, we examined whether iNOS is also expressed in beta cells after induction of acute pancreatitis (AP) in the rat. Pancreatic islets taken from AP animals and incubated for 60 min in the presence of 20.0 mmol/l glucose showed a decreased insulin secretory response to glucose. The basal insulin release at 1.0 mmol/l glucose was also moderately reduced. Experiments on the dynamics of insulin secretion from perfused pancreas revealed an impairment of both first and second phase of glucose-stimulated insulin release after the induction of AP. Confocal microscopy demonstrated that most of the beta cells in pancreas of rat with AP expressed strong immunoreactivity for iNOS. This was further confirmed by biochemical and Western blot analysis that showed a marked increase in iNOS protein expression and enzyme activity concomitant with a modest reduction in the cNOS protein and activity. Although the mechanisms underlying the defective insulin secretory response of beta cells seen during the early stage of AP are complex, the present finding suggests that the expression of iNOS and a marked iNOS-derived NO production in the beta cells may play at least a contributory role in the impairment of beta-cell function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12905064     DOI: 10.1007/s00441-003-0764-7

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  9 in total

1.  Three initial diets for management of mild acute pancreatitis: a meta-analysis.

Authors:  Wen-Bo Meng; Xun Li; Yu-Min Li; Wen-Ce Zhou; Xiao-Liang Zhu
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

Review 2.  Free radicals and the pancreatic acinar cells: role in physiology and pathology.

Authors:  M Chvanov; O H Petersen; A Tepikin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

3.  A novel inhibitor of inducible NOS dimerization protects against cytokine-induced rat beta cell dysfunction.

Authors:  Linlin Zhong; Tuan Tran; Tyler D Baguley; Sang Jun Lee; Adam Henke; Andrew To; Sijia Li; Shan Yu; Fabio A Grieco; Jason Roland; Peter G Schultz; Decio L Eizirik; Nikki Rogers; Arnab K Chartterjee; Matthew S Tremblay; Weijun Shen
Journal:  Br J Pharmacol       Date:  2018-07-14       Impact factor: 8.739

4.  Improving effect of combined inorganic nitrate and nitric oxide synthase inhibitor on pancreatic oxidative stress and impaired insulin secretion in streptozotocin induced-diabetic rats.

Authors:  Zahra Shabgard Shahraki; Narges Karbalaei; Marzieh Nemati
Journal:  J Diabetes Metab Disord       Date:  2020-03-18

5.  The role of nitric oxide synthase in post-operative hyperglycaemia.

Authors:  Ss Qader
Journal:  Libyan J Med       Date:  2008-09-01       Impact factor: 1.657

Review 6.  Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites.

Authors:  Andrea Verdugo-Meza; Jiayu Ye; Hansika Dadlani; Sanjoy Ghosh; Deanna L Gibson
Journal:  Nutrients       Date:  2020-05-15       Impact factor: 5.717

7.  Simplified Early Predictors of Severe Acute Pancreatitis: A Prospective Study.

Authors:  Maha Mohammed Maher; Basma Abdel Moneim Dessouky
Journal:  Gastroenterology Res       Date:  2010-01-20

8.  Non-liquid as initial meal in mild acute pancreatitis: Renewed meta-analysis.

Authors:  Yin Wang; Tai-Yun Zhao
Journal:  JGH Open       Date:  2018-01-10

Review 9.  Mechanisms of Post-Pancreatitis Diabetes Mellitus and Cystic Fibrosis-Related Diabetes: A Review of Preclinical Studies.

Authors:  Eleonóra Gál; Jurij Dolenšek; Andraž Stožer; László Czakó; Attila Ébert; Viktória Venglovecz
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-10       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.